Naoki Terasaka
Kitamura, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen.
Journal: Frontiers in pediatrics
Published: September 23, 2025
Safety, Efficacy and Treatment Patterns of rIX-FP in Previously Untreated Paediatric Haemophilia B Patients: A Retrospective Chart Review in Japan.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 11, 2025
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study.
Journal: Cardiology and therapy
Published: June 04, 2024
Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study.
Journal: Cardiology and therapy
Published: December 21, 2023
Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study.
Journal: Journal of cardiology
Published: July 10, 2022
Thrombotic and Cardiovascular Events and Treatment Patterns Among Patients Hospitalized with COVID-19 in Japan: An Analysis of a Nationwide Medical Claims Database.
Journal: Cardiology and therapy
Published: February 06, 2022
Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 22, 2020
Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists.
Journal: Bioorganic & medicinal chemistry letters
Published: March 31, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026